Printer Friendly

Browse Nervous system diseases topic

Drug therapy subtopic

Articles

1-99 out of 99 article(s)
Title Author Type Date Words
Taysha Gene Therapies receives orphan drug designation for TSHA-120. May 3, 2022 249
Hydrogen-Rich Water Improves Cognitive Ability and Induces Antioxidative, Antiapoptotic, and Anti-Inflammatory Effects in an Acute Ischemia-Reperfusion Injury Mouse Model. Lee, Dain; Choi, Jong-Il Report Oct 27, 2021 8561
VICO Therapeutics receives orphan-drug designation from FDA for VO659. Jul 29, 2021 181
VICO Therapeutics receives orphan-drug designation from FDA for VO659. Jul 29, 2021 182
MEMORY: Blood-brain barrier-crossing antihypertensives linked with better recall. Pass, Will Jul 1, 2021 973
Memory benefit seen with antihypertensives crossing blood-brain barrier. Pass, Will Jul 1, 2021 1146
Clene presents updated blinded efficacy data from Phase 2 RESCUE-ALS study. May 12, 2021 321
Rational design and synthesis of quinazoline derivatives. AlKharaz, Fatimah; Abudayeh, Zead; Abualassal, Qais; Hassouneh, Loay Apr 1, 2021 3624
Rational design and synthesis of quinazoline derivatives. AlKharaz, Fatimah; Abudayeh, Zead; Abualassal, Qais; Hassouneh, Loay Apr 1, 2021 3537
Boehringer Ingelheim, The Lieber Institute for Brain Development to Collaborate to Develop Centrally Acting COMT Inhibitors for Treatment of Neuropsychiatric Disorders. Disease/Disorder overview Mar 16, 2021 284
BIOGEN AND SAGE THERAPEUTICS COLLABORATE. Jan 1, 2021 1051
Hydrogen-Rich Water Improves Cognitive Ability and Induces Antioxidative, Antiapoptotic, and Anti-Inflammatory Effects in an Acute Ischemia-Reperfusion Injury Mouse Model. Lee, Dain; Choi, Jong-Il Report Jan 1, 2021 8559
Evaluation of Anticonvulsant Activity of 80% Methanolic Root Bark Extract and Solvent Fractions of Pentas schimperiana (A. Rich.) Vatke (Rubiaceae) in Swiss Albino Mice. Fisseha, Nebeyi; Shibeshi, Workineh; Bisrat, Daniel Jan 1, 2021 4287
BrainEver Receives FDA Orphan Drug Designation for BREN-02 for the Treatment of Amyotrophic Lateral Sclerosis. Nov 27, 2020 453
US FDA Accepts Biohaven's Supplemental New Drug Application of Nurtec ODT for the Preventive Treatment of Migraine. Oct 15, 2020 493
Bioasis has the best platform technology for shuttling drugs across the blood-brain barrier. Oct 10, 2020 1194
US FDA Grants Orphan Drug Designation to Ionis Treatment for Alexander Disease. Oct 1, 2020 412
A Multifaceted Evaluation of National Off-label Neurology Applications/Ulusal Endikasyon Disi Noroloji Basvurularinin Cok Yonlu Degerlendirilmesi. Yurtogullari, Sukran; Rahmanlar, Hanife; Alkan, Ali; Bayar, Banu; Gursoz, Hakki; Adatepe, Nurten Uzu Report Sep 1, 2020 4186
Current Medical Therapy and Future Trends in the Management of Glaucoma Treatment. Cvenkel, Barbara; Kolko, Miriam Aug 31, 2020 12683
Therapeutic Plasma Exchange as a Treatment for Autoimmune Neurological Disease. Nieto-Aristizabal, Ivana; Vivas, Alvaro J.; Ruiz-Montano, Pablo; Aragon, Cristian C.; Posso-Osorio, Aug 31, 2020 4652
Clinigen Gets US Orphan Drug Designation For ALS Treatment Aldesleukin. Jul 13, 2020 212
New drug good news for schizophrenia patients. Mar 12, 2020 467
Neuren Pharmaceuticals secures Rare Pediatric Disease designation for trofinetide to treat Rett Syndrome. Mar 5, 2020 389
NeuroSense Therapeutics wins ODD for ALS drug PrimeC and announces two clinical studies in ALS. Clinical report Feb 10, 2020 269
NeuroSense Therapeutics wins ODD for ALS drug PrimeC and announces two clinical studies in ALS. Clinical report Feb 10, 2020 265
Novel Drug For Schizophrenia To Hit The Market. Seema Prasad Dec 25, 2019 586
ITF Pharma wins FDA approval for expanding the existing label of TIGLUTIK to include administration via percutaneous endoscopic gastrostomy (PEG) tubes in ALS patients. Dec 16, 2019 301
ITF Pharma wins FDA approval for expanding the existing label of TIGLUTIK to include administration via percutaneous endoscopic gastrostomy (PEG) tubes in ALS patients. Dec 16, 2019 297
Neurodegenerative Disease Deaths Up in Former Soccer Players; Former Scottish soccer players also more often prescribed dementia-related medications than controls. Oct 23, 2019 270
A drug invented for just one patient. Gina Kolata Oct 11, 2019 1013
Annexon Biosciences' ANX005 granted US FDA fast track designation. Sep 25, 2019 127
Annexon Biosciences' ANX005 granted US FDA fast track designation. Sep 25, 2019 123
Global Central Nervous System Diseases Drug Delivery Research Report 2019. Report Aug 12, 2019 869
Quantitative Structure-Activity Relationship Analysis of Selective Rho Kinase Inhibitors as Neuro-regenerator Agents/Noro-rejenerator Ajan Olarak Secici Rho Kinaz Inhibitorlerinin Kantitatif Yapi-Etkinlik Iliski Analizi. Kesar, Seema; Paliwal, Sarvesh K.; Mishra, Pooja; Chauhan, Monika Report May 17, 2019 6660
New treatment to stop seizures sparks hope ahead of Purple Day. Mar 23, 2019 616
Iranian Scientists Use Nano-Conductors for Smart Treatment of Diabetes. Dec 12, 2018 610
H. Lundbeck and Otsuka report positive clinical phase II data for the combination treatment of brexpiprazole and sertraline for treatment of PTSD. Disease/Disorder overview Dec 3, 2018 426
H. Lundbeck and Otsuka report positive clinical phase II data for the combination treatment of brexpiprazole and sertraline for treatment of PTSD. Disease/Disorder overview Dec 3, 2018 422
H Lundbeck reports on clinical phase III study for Lu AF35700 in treatment-resistant schizophrenia. Oct 26, 2018 218
H Lundbeck reports on clinical phase III study for Lu AF35700 in treatment-resistant schizophrenia. Oct 26, 2018 219
H Lundbeck reports on clinical phase III study for Lu AF35700 in treatment-resistant schizophrenia. Oct 26, 2018 214
First Patient Dosed in Phase 2 Study of Karuna's Lead Product Candidate KarXT for the Treatment of Schizophrenia. Oct 15, 2018 698
Neurocrine Biosciences partners with Jnana Therapeutics to discover novel medicines to treat central nervous system disorders. Oct 10, 2018 246
Neurocrine Biosciences partners with Jnana Therapeutics to discover novel medicines to treat central nervous system disorders. Oct 10, 2018 242
FDA Grants Orphan Drug Designation for AMO Pharma's Rett Syndrome Treatment. Jun 18, 2018 195
Airway Dimensions in Children with Neurological Disabilities During Dexmedetomidine and Propofol Sedation for Magnetic Resonance Imaging Study/Norolojik Disabilitesi olan Cocuklarda Manyetik Rezonans Goruntuleme Calismasinda Deksmedetomidin ve Propofol ile Sedasyon Suresince Havayolu Boyutlari. Sriganesh, Kamath; Saini, Jitender; Theerth, Kaushik; Venkataramaiah, Sudhir Report Jun 1, 2018 4398
Evaluation of anticonvulsant activity of Saraca asoca flower (Roxb.) Wilde in Swiss albino mice. Srinivasa, K.; Kumara, Shashi; Neetha, C.S. Report Jun 1, 2018 3144
Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level. Gunaydin, Caner; Bilge, S. Sirri Report Jun 1, 2018 5151
The Role of Ionic Homeostasis in Cisplatin-Induced Neurotoxicity: A Preliminary Study. Unel, Cigdem Cengelli; Erol, Kevser Report Jun 1, 2018 4484
Old drug, new usage! May 18, 2018 359
Aggressive outbursts and emotional lability in a 16-year-old boy. Capote, Horacio A.; Asbach, Michael T. Case study May 1, 2018 2604
Anti-depressants and bladder drugs could increase risk of developing dementia; A British Medical Journal study found a link between some anticholinergic drugs and long-term memory or thinking problems. Apr 26, 2018 547
Promising New Treatment for ALS: Pimozide, a 50-year-old drug used to treat schizophrenia, may inhibit progression of amyotrophic lateral sclerosis (ALS). Apr 1, 2018 553
First Patient Enrolled in Biohaven Phase 3 Clinical Trial Evaluating Oral Dissolving Form of Rimegepant in Acute Treatment of Migraine. Mar 7, 2018 321
VA Adds New ALS Drug. Feb 1, 2018 190
Antidepressant Effects of Probucol on Early-Symptomatic YAC128 Transgenic Mice for Huntington's Disease. Nascimento-Castro, Cristine de Paula; Wink, Ana Claudia; da Fonseca, Victor Silva; Bianco, Claudia D Jan 1, 2018 11652
Successful Treatment of Unknown Drug-Induced Catatonia with Intravenous Midazolam in a Nine-Year-Old Girl. Oguz, Sinan; Tuygun, Nilden; Kesici, Selman; Karacan, Can Demir Clinical report Jan 1, 2018 1512
ICBII files orphan drug designation application with the US FDA for I[+ or -]-Synuclein-SMART Molecule for multiple system atrophy. Dec 6, 2017 212
ICBII files orphan drug designation application with the US FDA for I[+ or -]-Synuclein-SMART Molecule for multiple system atrophy. Dec 6, 2017 216
Biohaven's Second Efficacy and Safety Trial of Rimegepant for Acute Treatment of Migraine Completes Enrollment. Nov 28, 2017 327
Biohaven Completes Enrollment in Safety and Efficacy Trial of Rimegepant for Acute Treatment of Migraine. Nov 17, 2017 264
Hydra Biosciences and Boehringer Ingelheim Collaboration Initiates Clinical Trial of TRPC4/5 Inhibitor for CNS Disorders. Nov 3, 2017 244
Eugenol efficacy in preventing nicotine-induced seizures in mice. Karampour, Neda Sistani; Arzi, Ardeshir; Namazifar, Soroor Report Nov 1, 2017 2664
Lithium Chloride can Induce Differentiation of Human Immortalized RenVm Cells into Dopaminergic Neurons. Soleimani, Mitra; Ghasemi, Nazem Report Oct 1, 2017 2647
UCB's new antiepileptic drug BRIVIACT approved by US FDA as monotherapy treatment for partial-onset seizures in adults. Sep 15, 2017 310
UCB's new antiepileptic drug BRIVIACT approved by US FDA as monotherapy treatment for partial-onset seizures in adults. Sep 15, 2017 306
Marshall University School of Medicine approved for neurology residency program. Ferguson, Paul Report Sep 1, 2017 307
Mitsubishi Tanabe unveils intravenous RADICAVA therapy in the US for treating amyotrophic lateral sclerosis. Aug 9, 2017 240
Mitsubishi Tanabe unveils intravenous RADICAVA therapy in the US for treating amyotrophic lateral sclerosis. Aug 9, 2017 236
New ALS drug therapy. Aug 1, 2017 260
H. Lundbeck reports approval by US FDA of Abilify Maintena for extended-release injectable suspension for maintenance monotherapy treatment of bipolar I disorder (BP I) in adults. Jul 31, 2017 252
H. Lundbeck reports approval by US FDA of Abilify Maintena for extended-release injectable suspension for maintenance monotherapy treatment of bipolar I disorder (BP I) in adults. Jul 31, 2017 248
Glutamate's exciting roles in body, brain, and mind: a fertile future pharmacotherapy target. Nasrallah, Henry A. Editorial Jul 1, 2017 1504
Mind Games: Researchers are reaching for new levels using video games technology for dementia treatments. Stempak, Nicole Jun 22, 2017 1300
Wilson Therapeutics announces US Orphan Drug Designation receipt for WTX101 to treat ALS. Jun 12, 2017 284
Wilson Therapeutics announces US Orphan Drug Designation receipt for WTX101 to treat ALS. Jun 12, 2017 280
VACCINATION STATUS OF THE CHILDREN WITH NEUROLOGICAL DISORDERS AND ASSOCIATED FACTORS. Kondolot, Meda; Bayram, Ayse Kacar; Canpolat, Mehmet; Karakas, Faruk; Elmali, Ferhan; Gumus, Hakan; Report Mar 1, 2017 430
Three-Dimensional Organoid System Transplantation Technologies in Future Treatment of Central Nervous System Diseases. Wei, NaiLi; Quan, ZiFang; Tang, Hailiang; Zhu, JianHong Report Jan 1, 2017 9415
Targeting Oxidative Stress for Treatment of Glaucoma and Optic Neuritis. Kimura, Atsuko; Namekata, Kazuhiko; Guo, Xiaoli; Noro, Takahiko; Harada, Chikako; Harada, Takayuki Report Jan 1, 2017 6022
Rannasangpei Is a Therapeutic Agent in the Treatment of Vascular Dementia. Wu, Peng; Luo, Yuandai; Zhen, Lifang; Hu, Xianda; Shang, Ying; Liao, Yinuo; Xue, Huiyuan; Huang, Fuk Jan 1, 2016 6971
Scientists Identify New Drug Target to Treat ALS. Jun 10, 2015 469
Remission of episodic sweating attacks and comorbid depression in shapiro syndrome: case report/Shapiro sendromunda terleme ataklarinin ve komorbid depresyonun amitriptilin tedavisi ile remisyonu: olgu sunumu. Zincir, Selma Bozkurt; Zincir, Serkan; Kabak, Sevgi Gul Clinical report Dec 1, 2014 1341
Enhancing spatial memory: anxiolytic and antidepressant effects of Tapinanthus dodoneifolius (DC) Danser in mice. Simplice, Foyet Harquin; Emery, Tsala David; Herve, Ngatanko Abaissou Herve Report Jan 1, 2014 6246
Stretch-induced nerve injury: a proposed technique for the study of nerve regeneration and evaluation of the influence of gabapentin on this model. Machado, J.A.; Ghizoni, M.F.; Bertelli, J.; Teske, Gabriel C.; Teske, Guilherme C.; Martins, D.F.; M Report Nov 1, 2013 4428
Skin cells transformed into brain cells: promising path to better Parkinson's treatment. Jul 30, 2012 775
Promising path to better Parkinson's treatment. Jul 23, 2012 771
New drug targets to treat debilitating nervous system disease identified. Oct 17, 2011 361
DHEA/Pregnenolone. Report Jul 1, 2011 1379
Tx for pseudobulbar affect. Column May 1, 2011 761
Early antibiotic treatment in a child with PANDAS: a case report/PANDAS tanili bir cocukta erken antibiyotik tedavisi bir olgu sunumu. Ayaydin, Hamza; Abali, Osman Case study Jun 1, 2010 1185
Steroids for lumbar radiculopathy. Ebbert, Jon O.; Tangalos, Eric G. Clinical report Sep 15, 2009 863
Lineage 2 West Nile virus as cause of fatal neurologic disease in horses, South Africa. Venter, Marietjie; Human, Stacey; Zaayman, Dewald; Gerdes, Gertruida H.; Williams, June; Steyl, Joha Report Jun 1, 2009 5791
Centella asiatica water extract inhibits [iPLA.sub.2] and [cPLA.sub.2] activities in rat cerebellum. Barbosa, N.R.; Pittella, F.; Gattaz, W.F. Report Oct 1, 2008 2818
Tamiflu tied to pediatric neuropsychiatric events. Mechcatie, Elizabeth Clinical report Dec 1, 2006 620
Oral as good as intramuscular vitamin [B.sub.12] replacement. Nov 1, 2006 340
Neurologic disorders are high priority in R&D efforts. Aug 28, 2006 492
Anxiolytic and antidepressant-like activity of a standardized extract from Galphimia glauca. Herrera-Ruiz, M.; Jimenez-Ferrer, J.E.; De Lima, T.C.M.; Aviles-Montes, D.; Perez-Garcia, D.; Gonzal Clinical report Jan 1, 2006 3480
Cryptome to apply its drug discovery technology to neuroinflammatory diseases. Dec 1, 2004 380
New roles for lamotrigine. Hinkle, Janice L. Brief Article Feb 1, 2004 178

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |